Is CYTHW or NOBL a better dividend investment in 2026?

CYTHW currently yields 6250.00% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: CYTHW offers higher current income.

What is the dividend yield difference between CYTHW and NOBL?

CYTHW has a forward dividend yield of 6250.00% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 6246.00 percentage points.

Home › Compare › CYTHW vs NOBL

CYTHW vs NOBL: Dividend Comparison 2026

CYTHW yields 6250.00% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CYTHW wins by $547038161900822.19M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CYTHW

● Live price

6250.00%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$547038161900822.19M

Annual income

$530,345,833,482,145,900,000.00

Full CYTHW calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — CYTHW vs NOBL

📍 CYTHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CYTHW	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CYTHW + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CYTHW pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYTHW

Annual income on $10K today (after 15% tax)

$531,250.00/yr

After 10yr DRIP, annual income (after tax)

$450,793,958,459,824,000,000.00/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, CYTHW beats the other by $450,793,958,459,824,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYTHW + NOBL for your $10,000?

CYTHW: 50%NOBL: 50%

100% NOBL50/50100% CYTHW

Portfolio after 10yr

$273519080950411.09M

Annual income

$265,172,916,741,072,950,000.00/yr

Blended yield

96.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CYTHW right now

CYTHW

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-46.3

Piotroski

2/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYTHW buys

NOBL buys

No recent congressional trades found for CYTHW or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCYTHWNOBL

Forward yield	6250.00% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$547038161900822.19M ✓	$28.0K
Annual income after 10y	$530,345,833,482,145,900,000.00 ✓	$899.19
Total dividends collected	$545916230838674.88M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CYTHW vs NOBL ($10,000, DRIP)

Year	CYTHW Portfolio	CYTHW Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$635,700	$625,000.00	$11,120	$420.00	+$624.6K → CYTHW
2	$37,812,208	$37,132,009.35	$12,357	$458.31	+$37.80M → CYTHW
3	$2,104,624,511	$2,064,165,448.17	$13,721	$499.76	+$2104.61M → CYTHW
4	$109,626,980,731	$107,375,032,504.06	$15,227	$544.58	+$109626.97M → CYTHW
5	$5,344,419,538,811	$5,227,118,669,428.94	$16,885	$593.02	+$5344419.52M → CYTHW
6	$243,874,608,189,950	$238,156,079,283,422.40	$18,713	$645.34	+$243874608.17M → CYTHW
7	$10,417,442,627,867,752	$10,156,496,797,104,504.00	$20,724	$701.81	+$10417442627.85M → CYTHW
8	$416,612,895,336,954,560	$405,466,231,725,136,060.00	$22,938	$762.73	+$416612895336.93M → CYTHW
9	$15,600,306,933,342,350,000	$15,154,531,135,331,807,000.00	$25,372	$828.41	+$15600306933342.32M → CYTHW
10	$547,038,161,900,822,200,000	$530,345,833,482,145,900,000.00	$28,047	$899.19	+$547038161900822.19M → CYTHW

CYTHW vs NOBL: Complete Analysis 2026

CYTHW — Stock

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Full CYTHW Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this CYTHW vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYTHW vs SCHD CYTHW vs JEPI CYTHW vs O CYTHW vs KO CYTHW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.